Skip to main content
Solasia Pharma K.K. logo

Solasia Pharma K.K. — Investor Relations & Filings

Ticker · 4597 ISIN · JP3436500007 LEI · 529900A8W8K4LULTG564 T Manufacturing
Filings indexed 62 across all filing types
Latest filing 2017-05-15 Interim / Quarterly Rep…
Country JP Japan
Listing T 4597

About Solasia Pharma K.K.

https://solasia.co.jp/en/

Solasia Pharma K.K. is a specialty pharmaceutical company focused on oncology. The company's business model involves in-licensing promising drug candidates to develop and commercialize them for patients in Asian markets. Its portfolio is centered on addressing unmet medical needs in both cancer treatment and supportive care, aiming to improve patients' quality of life. Key commercialized products include Sancuso® for chemotherapy-induced nausea and vomiting (CINV), DARVIAS® for peripheral T-cell lymphoma (PTCL), and episil® oral liquid, a medical device for pain associated with oral mucositis. The development pipeline includes candidates for treating chemotherapy-induced peripheral neuropathy (CIPN) and colorectal cancer.

Recent filings

Filing Released Lang Actions
四半期報告書-第10期第1四半期(2017/01/01-2017/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Solasia Pharma K.K. covering the period from January 1, 2017, to March 31, 2017. It contains comprehensive financial statements, including the Statement of Financial Position, Statement of Profit or Loss, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows, all prepared in accordance with IFRS. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q1 2017
2017-05-15 Japanese
有価証券報告書-第9期(2016/01/01-2016/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) for Solasia Pharma K.K. for the fiscal year ending December 31, 2016. It contains comprehensive financial statements, management discussion, business overview, and audit information, which aligns with the definition of an Annual Report (10-K) in the provided schema. FY 2016
2017-03-31 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.